277 related articles for article (PubMed ID: 31778750)
1. Metformin reduces TRPC6 expression through AMPK activation and modulates cytoskeleton dynamics in podocytes under diabetic conditions.
Szrejder M; Rachubik P; Rogacka D; Audzeyenka I; Rychłowski M; Kreft E; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165610. PubMed ID: 31778750
[TBL] [Abstract][Full Text] [Related]
2. The TRPC6-AMPK Pathway is Involved in Insulin-Dependent Cytoskeleton Reorganization and Glucose Uptake in Cultured Rat Podocytes.
Rachubik P; Szrejder M; Rogacka D; Audzeyenka I; Rychłowski M; Angielski S; Piwkowska A
Cell Physiol Biochem; 2018; 51(1):393-410. PubMed ID: 30453301
[TBL] [Abstract][Full Text] [Related]
3. Insulin increases filtration barrier permeability via TRPC6-dependent activation of PKGIα signaling pathways.
Rogacka D; Audzeyenka I; Rachubik P; Rychłowski M; Kasztan M; Jankowski M; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1312-1325. PubMed ID: 28263796
[TBL] [Abstract][Full Text] [Related]
4. Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK.
Rogacka D; Audzeyenka I; Rychłowski M; Rachubik P; Szrejder M; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):115-125. PubMed ID: 29032153
[TBL] [Abstract][Full Text] [Related]
5. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of metformin on glomerular podocytes in diabetes.
Rogacka D; Piwkowska A
Biochem Pharmacol; 2021 Oct; 192():114687. PubMed ID: 34274355
[TBL] [Abstract][Full Text] [Related]
7. Insulin increases glomerular filtration barrier permeability through PKGIα-dependent mobilization of BKCa channels in cultured rat podocytes.
Piwkowska A; Rogacka D; Audzeyenka I; Kasztan M; Angielski S; Jankowski M
Biochim Biophys Acta; 2015 Aug; 1852(8):1599-609. PubMed ID: 25952906
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
Ma R; Wang Y; Xu Y; Wang R; Wang X; Yu N; Li M; Zhou Y
J Diabetes Res; 2021; 2021():8832114. PubMed ID: 34095318
[TBL] [Abstract][Full Text] [Related]
9. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the AMPK-PTEN pathway in insulin resistance induced by high glucose in cultured rat podocytes.
Rogacka D; Piwkowska A; Audzeyenka I; Angielski S; Jankowski M
Int J Biochem Cell Biol; 2014 Jun; 51():120-30. PubMed ID: 24747132
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
Li Z; Xu J; Xu P; Liu S; Yang Z
Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
[TBL] [Abstract][Full Text] [Related]
13. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner.
Sonneveld R; van der Vlag J; Baltissen MP; Verkaart SA; Wetzels JF; Berden JH; Hoenderop JG; Nijenhuis T
Am J Pathol; 2014 Jun; 184(6):1715-26. PubMed ID: 24731445
[TBL] [Abstract][Full Text] [Related]
14. Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation.
Jiang L; Ding J; Tsai H; Li L; Feng Q; Miao J; Fan Q
Exp Biol Med (Maywood); 2011 Feb; 236(2):184-93. PubMed ID: 21321315
[TBL] [Abstract][Full Text] [Related]
15. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
Ma R; Liu L; Jiang W; Yu Y; Song H
Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
[TBL] [Abstract][Full Text] [Related]
17. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
[TBL] [Abstract][Full Text] [Related]
18. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
Eisenreich A; Leppert U
Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
[TBL] [Abstract][Full Text] [Related]
19. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
20. Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes.
Shalygin A; Shuyskiy LS; Bohovyk R; Palygin O; Staruschenko A; Kaznacheyeva E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
